4DMedical (ASX:4DX) EBIT : A$-30.46 Mil (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical EBIT?

4DMedical's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$-15.56 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-30.46 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. 4DMedical's annualized ROC % for the quarter that ended in Dec. 2023 was -74.25%. 4DMedical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -352.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. 4DMedical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -15.28%.

4DMedical EBIT Historical Data

The historical data trend for 4DMedical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical EBIT Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

EBIT

-18.78

-36.75

-31.13

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial			-17.07	-19.68	-16.23	-14.90	-15.56

Competitive Comparison of 4DMedical's EBIT

For the Medical Devices subindustry, 4DMedical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where 4DMedical's EV-to-EBIT falls into.

4DMedical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-30.46 Mil.

4DMedical (ASX:4DX) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

4DMedical's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-47.114 * ( 1 - -0.3% )	/	( (18.624	+	108.662)	/ 2 )
=	-47.255342	/	63.643
=	-74.25 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	92.924	-	12.833	-	( 69.576	-	max(0, 17.072	-	78.539	+	69.576	))
=	18.624

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	143.734	-	7.326	-	( 47.879	-	max(0, 33.912	-	61.658	+	47.879	))
=	108.662

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

4DMedical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-31.112	/	( ( (9.257 + max(-7.407, 0))	+	(8.391 + max(-19.486, 0)) )	/	2 )
=	-31.112	/	( ( 9.257	+	8.391 )	/	2 )
=	-31.112	/	8.824
=	-352.58 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.584	+	0.665	+	7.483)	-	(12.833	+	2.004	+	1.302)
=	-7.407

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.021	+	1.112	+	11.646)	-	(7.326	+	0.31	+	25.629)
=	-19.486

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

4DMedical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-30.46	/	199.334
	=	-15.28 %

4DMedical EBIT Related Terms

Thank you for viewing the detailed overview of 4DMedical's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines